Log In
Print
BCIQ
Print
Print this Print this
 

LR769

Also known as: recombinant human coagulation factor VIIa

  Manage Alerts
Collapse Summary General Information
Company LFB S.A.
DescriptionRecombinant human Factor VIIa (rhFVIIa)
Molecular Target Factor VIIa
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationHemophilia
Indication DetailsTreat congenital hemophilia A and B; Treat hemophilia A and B
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$21.0M

$21.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today